43 studies found for:    Open Studies | "Adenoviridae Infections"
Show Display Options
Rank Status Study
1 Recruiting Adenovirus Vaccine Pregnancy Registry
Condition: Adenovirus
Intervention:
2 Unknown  Adenovirus and Fungal Load in Pediatric Stem Cell Transplant Patients
Conditions: Adenovirus;   Other Mycoses
Intervention:
3 Recruiting Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against Epstein Barr Virus, Adenovirus, And Cytomegalovirus
Conditions: Epstein-Barr Virus Infections;   Adenovirus;   Cytomegalovirus Infections
Intervention: Biological: Cytotoxic T Lymphocytes
4 Recruiting Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus
Conditions: Cytomegalovirus Infection;   Adenovirus Infection
Intervention: Biological: Dose Escalation Comparison
5 Not yet recruiting Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus
Conditions: Conjunctivitis;   Adenovirus.
Interventions: Drug: Ophthalmic gel (placebo);   Drug: Ganciclovir
6 Recruiting A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis
Conditions: Keratoconjunctivitis Due to Adenovirus;   Viral Shedding
Interventions: Drug: Zirgan;   Drug: genteal gel
7 Recruiting Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus
Conditions: Cytomegalovirus Infections;   Adenovirus Infections
Intervention: Other: Cell therapy
8 Recruiting Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE)
Conditions: Adenovirus Infection;   Epstein-Barr Virus Infections;   Cytomegalovirus Infections;   Stem Cell Transplant
Intervention: Biological: Multi-virus Specific T cells
9 Recruiting The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
Conditions: Herpesvirus;   Adenovirus;   Cytomegalovirus;   Human Papillomavirus;   Human Polyomavirus;   Influenza Virus;   Rhinovirus;   Coronavirus;   Respiratory Syncytial Virus
Intervention:
10 Recruiting Study of the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine
Condition: Tuberculosis
Intervention: Biological: Ad5Ag85A
11 Recruiting Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma
Condition: Locally Advanced or Metastatic Melanoma
Intervention: Biological: ICOVIR-5
12 Not yet recruiting Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer
Conditions: Transitional Cell Carcinoma;   Bladder Cancer;   Carcinoma in Situ;   Carcinoma in Situ Concurrent With Papillary Tumors
Interventions: Biological: CG0070 adenovirus vector;   Other: Control Arm: Quadruple Choice
13 Recruiting TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Recombinant Human Adenovirus Type 5 Injection;   Procedure: Transartery Chemoembolization
14 Recruiting Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma
Conditions: Brain Tumor;   Recurring Glioblastoma
Intervention: Biological: delta-24-RGD adenovirus
15 Recruiting ARMS - Rapidly Generated Multivirus-Specific CTLs for the Prophylaxis And Treatment of EBV, CMV, Adenovirus, HHV6, and BK Virus
Condition: Viral Infection
Intervention: Biological: Multi-virus-specific cytotoxic T lymphocytes
16 Recruiting Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer
Condition: Hormone Refractory Prostate Cancer
Intervention: Biological: ADENOVIRUS/PSA VACCINE
17 Recruiting Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21
Condition: Recurrent Prostate Cancer
Intervention: Biological: Adenovirus/PSA Vaccine
18 Recruiting Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA-016-00-VP;   Biological: VRCHIVADV014-00-VP
19 Not yet recruiting GOAT; Phase I Open Label Study of CGTG-102, a GM-CSF Encoding Oncolytic Adenovirus, for Advanced Cancers
Conditions: Tumors;   Solid Tumors
Intervention: Biological: CGTG-102
20 Unknown  Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Biological: Recombinant DNA- pVAX/L523S;   Biological: Recombinant adenovirus- Ad/L523S

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years